Drug Shortage Report for DOCETAXEL INJECTION
Report ID | 248843 |
Drug Identification Number | 02439336 |
Brand name | DOCETAXEL INJECTION |
Common or Proper name | DOCETAXEL INJECTION |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | DOCETAXEL |
Strength(s) | 10MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 16ML |
ATC code | L01CD |
ATC description | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | 2025-02-20 |
Actual start date | |
Estimated end date | 2025-04-30 |
Actual end date | 2025-02-03 |
Shortage status | Avoided shortage |
Updated date | 2025-02-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2025-02-03 | English | Compare |
v2 | 2025-01-28 | French | Compare |
v1 | 2025-01-28 | English | Compare |
Showing 1 to 3 of 3